Search research articles
Contact Us
Filters
Showing results (111-120 of 159) with videos related to
Page
of 16
Sort By:
AIDS (London, England)
|
November 4, 2000
Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids
P Barreiro, V Soriano, E Casas, et al.
HIV Medicine
|
March 4, 2016
Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy
V Estrada, S Monge, M D Gómez-Garre, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|
June 3, 1998
[Gastrointestinal hormones during minimal enteral feeding of sick premature infants]
M R Ordaz-Jiménez, J M Fernández-Celis, S Rivera-Rosas, et al.
ACS Measurement Science Au
|
February 26, 2024
Abiotic, Hybrid, and Biological Electrocatalytic Materials Applied in Microfluidic Fuel Cells: A Comprehensive Review
D V Estrada-Osorio, Ricardo A Escalona-Villalpando, M P Gurrola, et al.
Plos One
|
June 17, 2016
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D Lehmann, Bojana Jovanović, Xi Chen, et al.
HIV Clinical Trials
|
June 3, 2009
Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeks
F Pulido, V Estrada, J G Baril, et al.
HIV Medicine
|
September 7, 2013
The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery
S Serrano-Villar, S Moreno, M Fuentes-Ferrer, et al.
HIV Medicine
|
February 20, 2007
Cervical lipomatosis in HIV-infected patients: a case-control study
R Palacios, M J Galindo, J A Arranz, et al.
HIV Medicine
|
September 15, 2005
A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load
J A Arranz Caso, J C López, I Santos, et al.
HIV Medicine
|
January 10, 2013
Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study
E Ribera, M Larrousse, A Curran, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 159) with videos related to
Sort By:
Page
of 16
AIDS (London, England)
|
November 4, 2000
Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids
P Barreiro, V Soriano, E Casas, et al.
HIV Medicine
|
March 4, 2016
Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy
V Estrada, S Monge, M D Gómez-Garre, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|
June 3, 1998
[Gastrointestinal hormones during minimal enteral feeding of sick premature infants]
M R Ordaz-Jiménez, J M Fernández-Celis, S Rivera-Rosas, et al.
ACS Measurement Science Au
|
February 26, 2024
Abiotic, Hybrid, and Biological Electrocatalytic Materials Applied in Microfluidic Fuel Cells: A Comprehensive Review
D V Estrada-Osorio, Ricardo A Escalona-Villalpando, M P Gurrola, et al.
Plos One
|
June 17, 2016
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D Lehmann, Bojana Jovanović, Xi Chen, et al.
HIV Clinical Trials
|
June 3, 2009
Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeks
F Pulido, V Estrada, J G Baril, et al.
HIV Medicine
|
September 7, 2013
The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery
S Serrano-Villar, S Moreno, M Fuentes-Ferrer, et al.
HIV Medicine
|
February 20, 2007
Cervical lipomatosis in HIV-infected patients: a case-control study
R Palacios, M J Galindo, J A Arranz, et al.
HIV Medicine
|
September 15, 2005
A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load
J A Arranz Caso, J C López, I Santos, et al.
HIV Medicine
|
January 10, 2013
Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study
E Ribera, M Larrousse, A Curran, et al.
Page
of 16